Cardiac Biomarkers Market Research 2025: Size, Share, Trends Analysis & Forecasts 2024-2031 - Troponin Segment Dominates Due to High Specificity and Sensitivity - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type (Troponin, CK-MB, Myoglobin, BNP), Application (Myocardial Infarction, Congestive Heart Failure), and End User (Laboratory Testing, POC Testing ) - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.

The global cardiac biomarkers market, valued at $5.15 billion in 2023, is projected to reach $10.08 billion by 2031, growing at a robust CAGR of 8.8% from 2024 to 2031

This surge will be driven by an increasing prevalence of cardiovascular diseases, an aging population, advancements in biomarker technologies, and heightened healthcare spending. The integration of biomarkers into point-of-care testing also presents significant growth opportunities, despite challenges such as high costs and the availability of alternative diagnostic technologies.

Leading market players like Abbott Laboratories, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and others are shaping the competitive landscape with strategic developments and geographic expansion. In particular, the troponin segment dominates the market, benefiting from high specificity in diagnosing heart diseases and ongoing advancements in diagnostic technologies. Notably, Siemens Healthineers AG received FDA approval in October 2024 for a new high-sensitivity troponin I (TnIH) test aimed at predicting heart attacks.

Regarding applications, myocardial infarction remains the largest segment due to the rising incidence of heart diseases and mortality rates, along with increasing awareness around early diagnosis and advancements in testing methods. Meanwhile, laboratory testing holds the largest market share among end users, attributed to the proliferation of diagnostic labs, investment in healthcare infrastructure, and the availability of skilled professionals. Laboratory settings are particularly noted for their high throughput screening capacity, enhancing diagnostic efficiency.

Geographically, the Asia-Pacific region is forecasted to register the highest growth rate during the forecast period. This growth is primarily driven by the rising prevalence of cardiovascular diseases, alongside strong healthcare infrastructure and the adoption of biomarkers for diagnostic purposes across the region.

Cardiac Biomarkers Market Insights

Drivers

• Increasing Prevalence of Cardiovascular Diseases and Rising Geriatric Population
• Technological Advancements in Cardiac Biomarkers
• Increasing Healthcare Expenditure
• Increasing Cardiovascular Disease Awareness Programs

Restraints

• Limited Specificity and Sensitivity of Biomarkers
• High Cost of Biomarker Testing

Opportunity

• Introduction of Novel Biomarker Tests
• Integration of Biomarkers in Point-of-Care Testing

Challenges

• Alternative Diagnostic Technologies

Trends

• Focus on Multi-Analyte Panels

Regulatory Analysis

Porter's Five Forces Analysis

Companies Featured

• Abbott Laboratories (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Bio-Rad Laboratories Inc. (U.S.)
• Siemens Healthineers AG (Germany)
• Thermo Fisher Scientific Inc. (U.S.)
• BioMerieux SA (France)
• Danaher Corporation (U.S.)
• Creative Diagnostics (U.S.)
• Life Diagnostics Inc.?(U.S.)
• Randox Laboratories Ltd. (U.K)
• Becton
• Dickinson and Company (U.S.)
• QuidelOrtho Corporation (U.S.).

Scope of the Report:

Cardiac Biomarkers Market Assessment - by Type

• Troponin
• Creatine kinase MB (CK-MB)
• Myoglobin
• B-Type Natriuretic Peptide (BNP)
• N-terminal pro B-type natriuretic peptide (NT-proBNP)
• Other Types

Cardiac Biomarkers Market Assessment - by Application

• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Other Applications

Cardiac Biomarkers Market Assessment - by End User

• Laboratory Testing
• Point-of-Care Testing

Cardiac Biomarkers Market Assessment - by Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/mo0vxz

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.